DOI QR코드

DOI QR Code

Expression of bcl-2 and p53 in Induction of Esophageal Cancer Cell Apoptosis by ECRG2 in Combination with Cisplatin

  • Song, Hai-Yan (College of Basic Medicine, Xinxiang Medical University, Key Laboratory for Medical Tissue Regeneration of Henan Province) ;
  • Deng, Xiao-Hui (College of Basic Medicine, Xinxiang Medical University, Key Laboratory for Medical Tissue Regeneration of Henan Province) ;
  • Yuan, Guo-Yan (College of Basic Medicine, Xinxiang Medical University, Key Laboratory for Medical Tissue Regeneration of Henan Province) ;
  • Hou, Xin-Fang (The Affiliated Cancer Hospital of Zhengzhou University) ;
  • Zhu, Zhen-Dong (College of Basic Medicine, Xinxiang Medical University, Key Laboratory for Medical Tissue Regeneration of Henan Province) ;
  • Zhou, Li (College of Basic Medicine, Xinxiang Medical University, Key Laboratory for Medical Tissue Regeneration of Henan Province) ;
  • Ren, Ming-Xin (College of Basic Medicine, Xinxiang Medical University, Key Laboratory for Medical Tissue Regeneration of Henan Province)
  • 발행 : 2014.02.01

초록

Aim: To investigate the mechanisms of induction of apoptosis of esophageal cancer cells by esophageal cancer-related gene 2 (ECRG2) in combination with cisplatin (DDP). Methods: Hoechest staining was performed to analyze the effects of single ECRG2 and ECRG2 in combination with DDP on apoptosis of EC9706 cells. The expression levels of p53 and bcl-2 mRNA and protein were determined by RT-PCR and Western blotting, respectively. Results: The number of apoptotic cells after the treatment with ECRG2 in combination with DDP for 24 hours was more than that after the treatment with single ECRG2. RT-PCR and Western blotting showed that the expression levels of bcl-2 mRNA and protein were both down-regulated, while p53 mRNA and protein were both up-regulated in the cells treated with ECRG2 in combination with DDP compared with those given ECRG2 alone. Conclusion: ECRG2 in combination with DDP can enhance the apoptosis of EC9706 cells, possibly by down-regulating bcl-2 expression and up-regulating p53.

키워드

참고문헌

  1. Ando N, Kato H, Igaki H, et al (2012). A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized a vanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol, 19, 68-74. https://doi.org/10.1245/s10434-011-2049-9
  2. Cheng X, Shen Z, Yang J, et al (2008). ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability. J Biol Chem, 283, 5888-98.
  3. Cui Y, Wang J, Zhang X, et al (2003). ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem Biophys Res Commun, 302, 904-15. https://doi.org/10.1016/S0006-291X(03)00122-0
  4. Cui YP, Cheng XL, Song XJ (2008). ECRG2 gene deletion leading to excessive centrosome replication by p53 pathway. J Shanxi Med Univ, 39, 677-81.
  5. Ilson DH (2008). Esophageal cancer chemotherapy: recent advances. Gastrointest Cancer Res, 2, 85-92.
  6. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  7. Li H, Lakshmikanth T, Carbone E, et al (2012). A novel facet of tumor suppression by p53: Induction of tumor immunogenicity. Oncoimmunology, 1, 541-43. https://doi.org/10.4161/onci.19409
  8. Li MN, Huang G, Guo LP, et al (2005). Inhibitory effects of esophageal cancer related gene 2 on proliferation of human esophageal cancar cell EC9706. Zhonghua Yi Xue Za Zhi, 85, 2785-88.
  9. Liu G, Cescon DW, Zhai R, et al (2010). P53 Arg72Pro, MDM2 T309g and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus, 23, 36-39. https://doi.org/10.1111/j.1442-2050.2009.00960.x
  10. Mai WJ, Liu P, Wang W (2012). Characterization of the tilapia p53 gene and its role in chemical-induced apoptosis. Biotechnol Lett, 34, 1797-1805 https://doi.org/10.1007/s10529-012-0980-x
  11. Sjoquist KM, Burmeister BH, Smithers BM, et al (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol, 12, 681-92. https://doi.org/10.1016/S1470-2045(11)70142-5
  12. Song H, Song C, Wang H, et al (2012). Suppression of hepatocarcinoma model in vitro and in vivo by ECRG2 delivery using adenoviral vector. Cancer Gene Ther, 19, 875-79 https://doi.org/10.1038/cgt.2012.77
  13. Su T, Liu H, Lu S (1998). Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi, 20, 254-57.
  14. Su Xiang-Yu, Yin Hai-Tao, Li Su-Yi, et al (2012). Intervention Effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro. Asian Pacific J Cancer Prev, 13, 4531-36 https://doi.org/10.7314/APJCP.2012.13.9.4531
  15. Tan TT, White E (2008). Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. Adv Exp Med Biol, 615, 81-104. https://doi.org/10.1007/978-1-4020-6554-5_5
  16. Umar M, Upadhyay R, Khurana R (2012). Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population. Mol Biol Rep, 39, 1153-62 https://doi.org/10.1007/s11033-011-0844-9
  17. van Hagen P, Hulshof MC, van Lanschot JJ, et al (2012). Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med, 66, 2074-84.
  18. Vousden KH, Prives C (2009). Blinded by the light: the growing complexity of p53. Cell, 137, 413-31. https://doi.org/10.1016/j.cell.2009.04.037
  19. Wang Ting-Ting, Wang Shao-Kang, Huang Gui-Ling, et al (2012). Luteolin Induced-growth Inhibition and Apoptosis of Human Esophageal Squamous Carcinoma Cell Line Eca109 Cells in vitro. Asian Pacific J Cancer Prev, 13, 5455-61. https://doi.org/10.7314/APJCP.2012.13.11.5455
  20. Yue CM, Bi MX, Tan W, et al (2004). Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population. Int J Cancer, 108, 232-36. https://doi.org/10.1002/ijc.11560
  21. Zhang SS, Huang QY, Yang H, et al (2013). Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis. Ann Surg Oncol, 20, 2419-27 https://doi.org/10.1245/s10434-012-2859-4
  22. Zhao Y, Wang F, Shan S, et al (2010). Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk-A Meta-Analysis. Int J Med Sci, 7, 300-8.

피인용 문헌

  1. Bag-1L is a Stress-withstand Molecule Prevents the Downregulation of Mcl-1 and c-Raf Under Control of Heat Shock Proteins in Cisplatin Treated HeLa Cervix Cancer Cells vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4475
  2. Effects of Hypobaric Conditions on Apoptosis Signalling Pathways in HeLa Cells vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.5043
  3. Radio-Sensitization by Piper longumine of Human Breast Adenoma MDA-MB-231 Cells in Vitro vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3211
  4. Rice Bran Phytic Acid Induced Apoptosis Through Regulation of Bcl-2/Bax and p53 Genes in HepG2 Human Hepatocellular Carcinoma Cells vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3731
  5. A Functional SNP in the MDM2 Promoter Mediates E2F1 Affinity to Modulate Cyclin D1 Expression in Tumor Cell Proliferation vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3817
  6. Inhibitory effects of the recombinant human serine protease inhibitor Hespintor on the proliferation, migration and invasion of hepatocellular carcinoma cells vol.33, pp.2, 2014, https://doi.org/10.3892/or.2014.3670
  7. Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells vol.8, pp.5, 2014, https://doi.org/10.3892/etm.2014.1972
  8. Oleanolic acid rejuvenates testicular function through attenuating germ cell DNA damage and apoptosis via deactivation of NF-κB, p53 and p38 signalling pathways vol.69, pp.3, 2016, https://doi.org/10.1111/jphp.12668
  9. vol.23, pp.10, 2017, https://doi.org/10.3748/wjg.v23.i10.1796
  10. Persian shallot, Allium hirtifolium Boiss, induced apoptosis in human hepatocellular carcinoma cells vol.69, pp.4, 2017, https://doi.org/10.1007/s10616-017-0093-4
  11. Omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53/miR-34a/Bcl-2 axis vol.82, pp.7, 2017, https://doi.org/10.1134/S0006297917070082
  12. -glutathionylation and inducing apoptosis vol.8, pp.2, 2018, https://doi.org/10.1039/C7RA11935F